Silencing the full-length FOXP1 protein had previously been shown to inhibit CD19 expression in human DLBCL cell lines (15), and Cd19 expression at both the transcript and protein level was dramatically reduced in the A20 Foxp1 CRISPR clones. Here, FOXP1 is linked to diffuse large B-cell lymphoma.